Irene Pontikaki

Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry

Maria Elisabetta Zannin, Carolina Birolo, V. Gerloni et al. · The Journal of Rheumatology · 2012 · 155 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis

Elisabetta Miserocchi, Chiara Giuffré, M. Cornalba et al. · Clinical Rheumatology · 2020 · 137 citations

Medicine, Immunology, Pharmacotherapy +14

Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

V. Gerloni, Irene Pontikaki, M. Gattinara et al. · Annals of the Rheumatic Diseases · 2007 · 109 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis

Elisabetta Miserocchi, Giulio Modorati, Luigi Berchicci et al. · British Journal of Ophthalmology · 2015 · 107 citations

Medicine, Immunology, Pharmacotherapy +15

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

Serena Colafrancesco, Roberta Priori, Guido Valesini et al. · Frontiers in Pharmacology · 2017 · 106 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16